Teladoc Prices Convertible Senior Notes

Teladoc Prices Convertible Senior Notes

Teladoc said pre-market Thursday it priced its offering of $240 million aggregate principal amount of convertible senior notes due 2022 in a private offering to qualified institutional buyers. The size of the offering was boosted by $40 million from the previously announced offering size of $200 million. Teladoc has also granted the initial purchaser of the notes an option to purchase up to an additional $35 million aggregate principal amount […]

Read More ˃
U.K. Household Income Growth Comes in Below Expectations

U.K. Household Income Growth Comes in Below Expectations

U.K. household income growth came in below expectations, with the ex-bonus figure falling to 1.7% y/y in the three months to April and the with-bonus figure ebbing to 2.1% y/y growth. The respective median forecasts had been for 2.0% and 2.4% growth. Data for March were also revised lower, to 1.8% y/y in the case of the ex-bonus figure, down from the 2.1% rise originally reported. The May claimant count, […]

Read More ˃
TG Therapeutics to Present Abstracts on Two Therapies

TG Therapeutics to Present Abstracts on Two Therapies

TG Therapeutics said early Thursday that clinical abstracts featuring its two therapies targeting hematological malignancies and autoimmune diseases, TG-1101 and TGR-1202, have been selected for presentation at the upcoming 14th International Conference on Malignant Lymphoma (ICML), to be held from June 14-17 in Lugano, Switzerland. Among three oral presentations will be one explaining chemo-free triplet combination of TGR-1202, ublituximab, and ibrutinib is well tolerated and highly active in patients with […]

Read More ˃